MCID: HMT002
MIFTS: 64

Hematologic Cancer malady

Immune diseases, Blood diseases, Cancer diseases categories

Summaries for Hematologic Cancer

About this section
Sources:
8Disease Ontology, 63Wikipedia, 32MalaCards
See all sources

Fully expand this MalaCard

Export this MalaCard
Disease Ontology:8 An immune system cancer located in the hematological system that is characterized by uncontrolled cellular proliferation in blood, bone marrow and lymph nodes.

MalaCards: Hematologic Cancer, also known as hematologic neoplasm, is related to leukemia and acute leukemia. An important gene associated with Hematologic Cancer is PTHLH (parathyroid hormone-like hormone), and among its related pathways are Inhibition of Ribosome Biogenesis by p14(ARF) and TGF-Beta Pathway. The compounds estrogen and dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include the hematological system, bone and bone marrow, and related mouse phenotypes are embryogenesis and limbs/digits/tail.

Wikipedia:63 Hematological malignancies (British spelling \"Haematological\" malignancies) are the types of cancer... more...

Aliases & Classifications for Hematologic Cancer

About this section
Sources:
8Disease Ontology, 44Novoseek, 30LifeMap Discovery™, 22GTR, 60UMLS, 56SNOMED-CT, 34MeSH, 39NCIt
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases
Anatomical: Immune diseases, Blood diseases


Aliases & Descriptions:

hematologic cancer 8 44 30
hematologic neoplasm 8 22
hematopoietic and lymphoid system tumor 8
malignant hematopoietic neoplasm 8
hematologic malignancies 44
hematopoietic neoplasms 60
hematologic malignancy 8
hematopoietic neoplasm 8
hematologic neoplasms 60
hematological tumors 8
hematopoietic tumors 8
hematopoietic cancer 8
blood cancer 8


External Ids:

Disease Ontology8 DOID:2531
MeSH34 D019337
NCIt39 C27134

Related Diseases for Hematologic Cancer

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases related to Hematologic Cancer via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 471)
idRelated DiseaseScoreTop Affiliating Genes
1leukemia30.8ODC1, BRCA1, BRCA2, TP53, BCL2L11, FCER2
2acute leukemia30.6CSF3, IL2
3neutropenia30.6TYMS, CSF3, MBL2
4graft versus host disease30.4IL2RA, IL2, CSF3, IL2RB
5thyroiditis30.2MBL2
6hepatitis30.2IL2RB
7multiple myeloma30.2CSF3, TP53
8aplastic anemia30.2BRCA1, BRCA2
9hairy cell leukemia30.2IL2, IL2RA, IL2RB
10pneumonia30.2TYMS, MBL2, CSF3, IL2RB
11chronic lymphocytic leukemia30.2IL2RA, BRCA2, FCER2, IL2
12eosinophilia30.2MBL2, IL2RA, IL2RB, FCER2, IL2
13myeloid leukemia30.1CSF3
14hypercalcemia30.1PTHLH
15adult t-cell leukemia30.1IL2RA, PTHLH
16rhabdomyosarcoma30.1TP53, RB1
17adult acute lymphocytic leukemia30.1TYMS
18aspergillosis30.1MBL2
19diarrhea30.1TYMS, IL2
20myeloma30.1FCER2, IL2, RB1, CSF3, PTHLH, BCL2L11
21non-hodgkin lymphoma30.1IL2, IL2RB, CSF3, IL2RA, FCER2
22systemic lupus erythematosus30.1MBL2, IL2, FCER2, IL2RA, IL2RB
23sarcoma30.1TP53, IL2, RB1, BRCA2, ODC1, FCER2
24hodgkin's lymphoma30.1IL2RA, CSF3, BRCA2, IL2, BRCA1, IL2RB
25ovarian cancer30.0TP53, TYMS, IL2, BRCA2, BRCA1
26thymoma29.9IL2
27meningitis29.9MBL2
28myelodysplastic syndromes29.9CSF3
29pancreatitis29.9BRCA2
30hemophagocytic lymphohistiocytosis29.9IL2RA
31nephrotic syndrome29.9IL2RA
32acquired immunodeficiency syndrome29.9IL2
33inflammatory bowel disease29.9IL2
34anaplastic large cell lymphoma29.9IL2RA, IL2RB
35urticaria29.9FCER2
36hepatitis b29.9MBL2, IL2
37alzheimer's disease29.9IL2RB
38mycosis fungoides29.9IL2RA, IL2RB, IL2
39diphtheria29.9IL2RA, IL2RB, IL2
40acute lymphocytic leukemia29.9RB1, TYMS, CSF3, PTHLH
41sarcoidosis29.9IL2RA, IL2RB, IL2, FCER2
42osteosarcoma29.8TP53, PTHLH, RB1, ODC1, TYMS
43prostate cancer29.8ODC1, RB1, BCL2L11, PTHLH, TP53, BRCA2
44breast cancer29.8BRCA1, BRCA2, ODC1
45t-cell leukemia29.8IL2, IL2RA, FCER2, PTHLH, IL2RB, TYMS
46melanoma29.8ODC1, BRCA2, RB1, IL2RB, IL2, BCL2L11
47retinoblastoma29.8TP53, RB1, BRCA2, BRCA1, ODC1, TYMS
48burkitt's lymphoma29.8ODC1, BRCA2, CSF3, RB1, TYMS, IL2RA
49nijmegen breakage syndrome29.7BRCA1
50bloom syndrome29.7BRCA2, BRCA1

Graphical network of the top 20 diseases related to Hematologic Cancer:



Diseases related to hematologic cancer

Clinical Features for Hematologic Cancer

About this section

Drugs & Therapeutics for Hematologic Cancer

About this section
Sources:
5CenterWatch, 41NIH Clinical Center, 6ClinicalTrials, 30LifeMap Discovery™, 60UMLS, 40NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Hematologic Cancer

Drug clinical trials:

Search ClinicalTrials for Hematologic Cancer

Search NIH Clinical Center for Hematologic Cancer

Search CenterWatch for Hematologic Cancer

Cell-based therapeutics:


LifeMap Discovery
The database of embryonic development, stem cell research and regenerative medicine
Read about Hematologic Cancer cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Hematologic Cancer:
ALD-151, umbilical cord blood cells for hematologic and immunodefeciency diseases
Allocord, cord blood-derived hematopoietic progenitor cells for hematopoietic reconstitution
Co-infusion of umbilical cord blood and haploidentical CD34+ cells for hematological diseases
Ducord, umbilical cord blood-derived hematopoietic progenitor cells for hematopoietic reconstitution
Expanded cord blood hematopoietic stem cells for hematologic malignancies
Hemacord
Hematopoietic stem cells for treatment of hematologic malignancies
StemEx
Umbilical cord blood-derived hematopoietic progenitor cells for hematopoietic reconstitution
Umbilical cord blood-derived hematopoietic progenitor cells for hematopoietic reconstitution
Embryonic/Adult Cultured Cells Related to Hematologic Cancer:
Umbilical cord blood ALDH+ cells (ALD-151), PMID: 10430905
Umbilical cord blood-derived hematopoietic progenitor cells (Allocord), PMID: 11953027
Peripheral blood-derived hematopoietic stem cells
Umbilical cord blood-derived hematopoietic progenitor cells (Ducord), PMIDs: 22698485, 21810098, 23711284, 21277377
Mesenchymal Precursor Cells (STRO-3 selected), PMID: 21396596
Expanded umbilical cord blood-derived hematopoietic stem cells, PMID: 21396596
Umbilical cord blood-derived hematopoietic progenitor cells (HEMACORD, PMID: 9828244
Bone marrow-derived hematopoietic stem cells
Umbilical cord blood stem/progenitor cells (Stemex), PMID: 18209724
Umbilical cord blood stem/progenitor cells (Stemex), PMID: 18209724
Umbilical cord blood-derived hematopoietic stem cells (family), PMID: 20676147
Umbilical cord blood-derived hematopoietic stem cells (family)

Genetic Tests for Hematologic Cancer

About this section
Sources:
22GTR
See all sources

Genetic tests related to Hematologic Cancer:

id Genetic test Affiliating Genes
1 Hematologic Neoplasm22

Anatomical Context for Hematologic Cancer

About this section
Sources:
32MalaCards, 14FMA
See all sources

MalaCards organs/tissues related to Hematologic Cancer:

32
Bone, Bone marrow, Lymph node, Breast, Testis, Testes, Skin, Prostate, Brain

FMA organs/tissues related to Hematologic Cancer:

14
The hematological system

Animal Models for Hematologic Cancer or affiliated genes

About this section
Sources:
36MGI
See all sources

Publications for Hematologic Cancer

About this section
Sources:
50PubMed
See all sources

Articles related to Hematologic Cancer:

(show top 50)    (show all 56)
idTitleAuthorsYear
1
Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer. (23533652)
2013
2
Internet-based program for coping with cancer: a randomized controlled trial with hematologic cancer patients. (22565413)
2013
3
Xist RNA is a potent suppressor of hematologic cancer in mice. (23415223)
2013
4
Refining the UGT1A haplotype associated with irinotecan-induced hematological toxicity in metastatic colorectal cancer patients treated with 5-fluorouracil/irinotecan-based regimens. (23386248)
2013
5
Evaluation of MycAssaya8c Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. (23620764)
2013
6
Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy. (24286231)
2013
7
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. (22965953)
2012
8
Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study. (22099500)
2012
9
A stapled BIM peptide overcomes apoptotic resistance in hematologic cancers. (22622039)
2012
10
Febrile neutropenia incidence and hematological toxicity with the FEC100-docetaxel regimen in the treatment of early-stage breast cancer. (22713627)
2012
11
p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. (23029260)
2012
12
Improving access to information and support for patients with less common cancers: hematologic cancer patients' views about Web-based approaches. (22189354)
2011
13
Physical activity and hematologic cancer prevention. (21113763)
2011
14
Impact of influenza A(H1N1) in pediatric patients with cancer and hematologic disorders: establishment of information sharing system for swine influenza. (22185798)
2011
15
Evolving information priorities of hematologic cancer survivors, caregivers, and other relatives. (20119694)
2010
16
Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. (20138081)
2010
17
Mesial temporal sclerosis as a complication of hematologic cancer. (19434437)
2009
18
Managed care considerations: hematologic cancer as a chronic disease. (19119536)
2008
19
Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. (18344563)
2008
20
Posaconazole prophylaxis in hematologic cancer. (17526090)
2007
21
A yeast two-hybrid system using Sp17 identified ropporin as a novel cancer-testis antigen in hematologic malignancies. (17551920)
2007
22
Wheat grass juice may improve hematological toxicity related to chemotherapy in breast cancer patients: a pilot study. (17571966)
2007
23
Posaconazole prophylaxis in hematologic cancer. (17526089)
2007
24
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. (17683622)
2007
25
Posaconazole prophylaxis in hematologic cancer. (17522407)
2007
26
Posaconazole prophylaxis in hematologic cancer. (17526091)
2007
27
Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. (17607669)
2007
28
Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies. (17476281)
2007
29
Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. (17516403)
2007
30
Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. (16418736)
2006
31
Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (16877725)
2006
32
Patient-rated emotional and physical functioning among hematologic cancer patients during hospitalization for stem-cell transplantation. (15580279)
2005
33
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide. (16129844)
2005
34
The spermatozoa protein, SLLP1, is a novel cancer-testis antigen in hematologic malignancies. (15475442)
2004
35
In vitro chemosensitivity testing of hematological cancer patients: detection of ornithine decarboxylase. (12528799)
2003
36
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (12351606)
2002
37
Report of the fifteenth international symposium of the foundation for promotion of cancer research: new horizons in the diagnosis and treatment of hematological malignancies based on molecular genetic features. (12417606)
2002
38
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. (12239138)
2002
39
Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. (11919251)
2002
40
Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues. (11368411)
2001
41
In vitro chemosensitivity testing of hematological cancers: immunohistochemical detection of ornithine decarboxylase. (10587289)
1999
42
Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery. (10650787)
1999
43
Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)]. (9020948)
1997
44
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses. (7537799)
1995
45
Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers. (8358720)
1993
46
Changes in hematologic parameters during treatment with medroxyprogesterone acetate for breast cancer. (1828463)
1991
47
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. (2185337)
1990
48
Autologous bone marrow transplantation for hematologic cancer. (2236163)
1990
49
Alzheimer's disease and senile dementia: genetic relationships to Down's syndrome and hematologic cancer. (154163)
1979
50
Albinism: hematologic-storage disease, susceptibility to skin cancer, and optic neuronal defects shared in all types of oculocutaneous and ocular albinism. (546241)
1979

Genetic Variations for Hematologic Cancer

About this section

Expression for genes affiliated with Hematologic Cancer

About this section
Sources:
1BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Hematologic Cancer

Search GEO for disease gene expression data for Hematologic Cancer.

Pathways for genes affiliated with Hematologic Cancer

About this section
Sources:
51QIAGEN, 37NCBI BioSystems Database, 12EMD Millipore, 53Reactome, 52R&D Systems, 29KEGG, 49PharmGKB, 4Cell Signaling Technology
See all sources

Pathways related to Hematologic Cancer according to GeneCards/GeneDecks:

(show all 38)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.4TP53, RB1
2
Hide members
9.3IL2, IL2RB, IL2RA
3
Hide members
9.3IL2, IL2RB, IL2RA
49.3IL2, IL2RB, IL2RA
5
Immune response IL-2 activation and signaling pathway
Hide members
9.3IL2, IL2RB, IL2RA
6
Hide members
9.3IL2, IL2RB, IL2RA
79.3IL2, IL2RB, IL2RA
8
Hide members
9.3IL2, IL2RB, IL2RA
9
Hide members
9.3IL2, IL2RB, IL2RA
109.3IL2, IL2RB, IL2RA
119.3IL2, IL2RB, IL2RA
12
Hide members
9.3IL2RA, IL2RB, IL2
139.2TP53, BRCA1
149.2TP53, BRCA1
159.2FCER2, IL2RA, CSF3
169.2BRCA1, RB1, TYMS
179.0TP53, TYMS
18
Hide members
9.0BRCA1, RB1, TP53
19
Hide members
9.0TP53, RB1, BRCA1
20
Hide members
8.9BRCA2, RB1, TP53
21
Hide members
8.9IL2RA, IL2RB, IL2, FCER2
228.9RB1, IL2, TP53
23
DNA damage Role of Brca1 and Brca2 in DNA repair
Hide members
8.8BRCA1, BRCA2, TP53
24
Hide members
8.8TP53, IL2RA, CSF3
258.7IL2, IL2RB, IL2RA, CSF3
26
Hide members
8.7BRCA1, BRCA2, RB1, TYMS
27
Hide members
8.7RB1, IL2RA, IL2RB, IL2, BCL2L11
288.5BRCA1, BRCA2, RB1, TP53
298.5BRCA1, BRCA2, RB1, TP53
30
Hide members
8.5BRCA1, BRCA2, RB1, TP53
31
Hide members
8.4TP53, IL2, IL2RB, IL2RA
32
Hide members
8.2RB1, IL2RA, IL2, BCL2L11, TP53
338.2TP53, IL2, IL2RB, IL2RA, RB1
348.2BRCA1, BRCA2, TYMS, TP53
35
Hide members
7.9CSF3, IL2RA, IL2RB, IL2, TP53
36
Hide members
7.5BRCA1, BRCA2, IL2RA, IL2, FCER2, TP53
377.2TP53, BRCA1, CSF3, IL2RA, IL2RB, IL2
38
Hide members
7.0BRCA1, CSF3, RB1, IL2RA, IL2RB, IL2

Compounds for genes affiliated with Hematologic Cancer

About this section
Sources:
44Novoseek, 49PharmGKB, 28IUPHAR, 11DrugBank, 59Tocris Bioscience, 24HMDB, 2BitterDB
See all sources

Compounds related to Hematologic Cancer according to GeneCards/GeneDecks:

(show top 50)    (show all 155)
idCompoundScoreTop Affiliating Genes
1estrogen4410.6MBL2
2dexamethasone44 49 28 1113.3RB1, FCER2
3resveratrol44 59 11 2413.1ODC1, BRCA2
4serine449.8BRCA1, IL2RB, FCER2
5p003449.8BRCA2, RB1, IL2RB
6cycloheximide449.7BRCA1, BRCA2, IL2RB
7denileukin diftitox44 49 1111.4IL2, IL2RB, IL2RA
8valine449.3PTHLH, ODC1, TYMS
9con a449.3IL2RA, MBL2, IL2, IL2RB
10okt3449.3FCER2, IL2, IL2RB, IL2RA
11adriamycin449.2TYMS, RB1, CSF3, ODC1
122,5-oligoadenylate449.2ODC1, IL2RB, IL2, IL2RA
13tamoxifen44 49 28 1112.2IL2RB, TYMS, IL2, PTHLH
14alemtuzumab44 1110.1IL2RA, CSF3, IL2RB, IL2
15levamisole44 1110.0IL2, IL2RB, IL2RA, TYMS
16neopterin449.0MBL2, IL2RA, FCER2, IL2, IL2RB
17indole-3-carbinol448.7ODC1, BRCA1, BRCA2, TP53
18mycophenolate mofetil44 49 1110.7IL2RA, CSF3, IL2, IL2RB
19aphidicolin448.7RB1, TP53, TYMS, BRCA1
20rapamycin448.7BCL2L11, IL2, ODC1, IL2RB, RB1, IL2RA
21prednisolone44 28 1110.6MBL2, IL2RA, IL2, IL2RB, CSF3, PTHLH
22ionomycin448.6PTHLH, FCER2, IL2RA, IL2RB, IL2
232-chlorodeoxyadenosine448.6TP53, CSF3, IL2RA, IL2
24paraffin448.5MBL2, PTHLH, FCER2, IL2RA, BRCA2, BRCA1
25thymidylate448.4TYMS, ODC1, BRCA1, RB1, TP53
26topotecan44 119.2CSF3, BRCA1, TYMS, TP53
27carboplatin44 49 1110.2CSF3, BRCA1, RB1, TYMS, TP53
28actinomycin d448.2TP53, ODC1, RB1, IL2, BCL2L11, PTHLH
29steroid448.2IL2RB, RB1, MBL2, PTHLH, BRCA2, BRCA1
30camptothecin44 59 1110.2TYMS, TP53, BRCA1, BRCA2, RB1
31bleomycin44 119.1IL2RA, PTHLH, BRCA2, CSF3, BRCA1, TP53
32folate448.0ODC1, IL2RA, BRCA2, BRCA1, TYMS
33progesterone44 59 28 11 2412.0BRCA2, BRCA1, MBL2, TP53, RB1, IL2RB
34genistein44 28 59 2 11 2412.9ODC1, BRCA1, BRCA2, IL2RA, IL2RB, IL2
35docetaxel44 49 59 1110.9BRCA1, BRCA2, TP53, TYMS, CSF3
36h2o2447.9TP53, BCL2L11, RB1, BRCA1, ODC1, BRCA2
37hydroxyurea44 49 119.8ODC1, TP53, TYMS, CSF3, BRCA2, BRCA1
38methotrexate44 49 119.7ODC1, IL2RA, BRCA1, IL2RB, BRCA2, CSF3
39doxorubicin44 49 119.6CSF3, TP53, IL2RA, ODC1, BRCA1, RB1
40vincristine44 49 119.6RB1, IL2RA, TP53, PTHLH, BRCA2, ODC1
415fluorouracil447.4TYMS, TP53, IL2RA, RB1, CSF3, BRCA1
42mitomycin c447.3TP53, TYMS, IL2, RB1, CSF3, BRCA1
43paclitaxel44 49 119.3ODC1, TYMS, BCL2L11, BRCA2, TP53, BRCA1
44retinoic acid44 248.2TP53, FCER2, IL2RB, RB1, BRCA2, CSF3
45etoposide44 49 59 1110.2TYMS, BRCA2, IL2RA, TP53, CSF3, RB1
46cyclophosphamide44 49 119.2TP53, IL2RB, CSF3, IL2RA, IL2, PTHLH
47tyrosine447.0BCL2L11, FCER2, IL2, MBL2, IL2RB, IL2RA
48vegf446.5MBL2, BRCA1, IL2RB, IL2RA, CSF3, TYMS
49cisplatin44 49 59 119.4BRCA1, BRCA2, PTHLH, CSF3, RB1, TYMS
50thymidine44 246.8TP53, PTHLH, FCER2, IL2, IL2RB, IL2RA

GO Terms for genes affiliated with Hematologic Cancer

About this section
Sources:
16Gene Ontology
See all sources

Biological processes related to Hematologic Cancer according to GeneCards/GeneDecks:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1regulation of T cell homeostatic proliferationGO:0460139.8IL2, IL2RA
2regulation of transcription involved in G1/S transition of mitotic cell cycleGO:0000839.6TYMS, RB1
3positive regulation of cell cycle arrestGO:0711589.3TP53, BRCA1
4positive regulation of activated T cell proliferationGO:0421049.3IL2, IL2RA
5response to X-rayGO:0101659.1TP53, BRCA2
6DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorGO:0069789.0TP53, BRCA2, BRCA1
7double-strand break repairGO:0063028.9BRCA1, BRCA2, TP53
8positive regulation of cell proliferationGO:0082848.9ODC1, CSF3, IL2, PTHLH
9positive regulation of transcription from RNA polymerase II promoterGO:0459448.1BRCA1, CSF3, RB1, IL2, TP53

Molecular functions related to Hematologic Cancer according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1interleukin-2 bindingGO:0199769.8IL2RB, IL2RA
2interleukin-2 receptor activityGO:0049119.5IL2RB, IL2RA

Products for genes affiliated with Hematologic Cancer

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Hematologic Cancer

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
34MeSH
35MESH via Orphanet
36MGI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
50PubMed
51QIAGEN
57SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet